Patents by Inventor Staffan Schantz

Staffan Schantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Millicapsule formulations comprising polyunsaturated free fatty acids
    Patent number: 10512611
    Abstract: Capsular dosage forms containing polyunsaturated fatty acid (PUFA) compositions are provided herein. In certain embodiments, unit dosage forms comprising a plurality of millicapsules containing a PUFA composition therein are provided as well as their methods of use and manufacture. In certain embodiments, capsular dosage forms are provided herein that include a unit dosage form comprising a plurality of millicapsules containing a polyunsaturated free fatty acid substantially in free acid form. In some embodiments, the PUFA composition is Epanova®.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: December 24, 2019
    Assignee: Omthera Pharmaceuticals Inc.
    Inventors: Hironori Kubota, Etienne Thierry Charles Rogeau, Tohru Amemiya, Julien Georges Meissonnier, Anders Gillis Holmén, Andreas Rådevik, Hans Carlsson, Bengt Staffan Schantz
  • Film coating
    Patent number: 7959947
    Abstract: A film coating composition suitable for use in coating pharmaceutical formulations comprising a) an acrylic polymer dispersion, e.g. an ethylacrylate/methylmethacrylate copolymer such as Eudragit NE30D, b) a surfactant, c) sodium stearyl fumarate, and d) a water-containing liquid useful for the achievement of controlled release from pharmaceutical formulations such as tablets, pellets, etc.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: June 14, 2011
    Assignee: AstraZeneca AB
    Inventors: Arne Hölzer, Jan-Erik Löfroth, Staffan Schantz
  • Film coating
    Patent number: 7815938
    Abstract: A film coating composition suitable for use in coating pharmaceutical formulations to provide modified release comprising a dispersion which includes: a) an acrylic polymer, b) a vinyl acetate polymer, and c) a water-containing liquid. The film coat is useful for the achievement of modified release from pharmaceutical formulations such as tablets, pellets, etc.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: October 19, 2010
    Assignee: AstraZeneca AB
    Inventors: Jan-Erik Löfroth, Staffan Schantz, Anders Welin, Lars Johan Pontus de Verdier Hjärtstam
  • Film coating
    Publication number: 20050256255
    Abstract: The present invention provides a novel film coating dispersion obtainable by the polymerization of the following monomers in water: acrylic acid or an ester thereof in the range 40 to 80% by weight; methacrylic acid or an ester thereof in the range 20 to 60% by weight; and a polymerizable surfactant in the range 0.01 to 9% by weight. The dispersion is suitable for coating pharmaceutical formulations to provide controlled release of the active ingredient.
    Type: Application
    Filed: April 9, 2003
    Publication date: November 17, 2005
    Inventors: Ola Karlsson, Lars Johan Hjartstam, Staffan Schantz
  • New film coating
    Publication number: 20050089574
    Abstract: A film coating composition suitable for use in coating pharmaceutical formulations to provide modified release comprising a dispersion which includes: a) an acrylic polymer, b) a vinyl acetate polymer, and c) a water-containing liquid. The film coat is useful for the achievement of modified release from pharmaceutical formulations such as tablets, pellets, etc.
    Type: Application
    Filed: September 16, 2004
    Publication date: April 28, 2005
    Inventors: Jan-Erik Lofroth, Staffan Schantz, Anders Welin, Lars, Johan, , Hjartstam
  • Film coating
    Patent number: 6827947
    Abstract: A film coating composition suitable for use in coating pharmaceutical formulations to provide modified release comprising a dispersion which includes: a) an acrylic polymer, b) a vinyl acetate polymer, and c) a water-containing liquid. The film coat is useful for the achievement of modified release from pharmaceutical formulations such as tablets, pellets, etc.
    Type: Grant
    Filed: June 16, 2003
    Date of Patent: December 7, 2004
    Assignee: AstraZeneca AB
    Inventors: Jan-Erik Löfroth, Staffan Schantz, Anders Welin, Lars Johan Pontus de Verdier Hjartstam
  • Film coating
    Publication number: 20040058001
    Abstract: A film coating composition suitable for use in coating pharmaceutical formulations comprising a) an acrylic polymer dispersion, e.g. an ethylacrylate/methylmethacrylate copolymer such as Eudragit NE30D, b) a surfactant, c) sodium stearyl fumarate, and d) a water-containing liquid useful for the achievement of controlled release from pharmaceutical formulations such as tablets, pellets, etc.
    Type: Application
    Filed: July 11, 2003
    Publication date: March 25, 2004
    Inventors: Arne Holzer, Jan-Erik Lofroth, Staffan Schantz
  • New film coating
    Publication number: 20040030033
    Abstract: A film coating composition suitable for use in coating pharmaceutical formulations to provide modified release comprising a dispersion which includes: a) an acrylic polymer, b) a vinyl acetate polymer, and c) a water-containing liquid. The film coat is useful for the achievement of modified release from pharmaceutical formulations such as tablets, pellets, etc.
    Type: Application
    Filed: June 16, 2003
    Publication date: February 12, 2004
    Inventors: Jan-Erick Lofroth, Staffan Schantz, Anders Welin, Lars Johan Pontus de Verdier Hjarstam